Projects per year
Personal profile
Chinese Name
Biography
Prof. Yu received his undergraduate education at the Henan University of Traditional Chinese Medicine, and obtained his PhD degree in biochemistry from the Hong Kong University of Science and Technology. Before joining the Hong Kong Baptist University, Prof. Yu once worked at China Pharmaceutical University, Nagasaki University, Hong Kong University of Science and Technology, Xiamen University and University of Macau. Prof. Yu is known for his research in herbal pharmacology, and in processing of Chinese medicinal materials. He has published more than 200 peer-reviewed research papers.
Consun Pharmaceutical Group Limited and Laboratory JaneClare Limited in collaboration with Prof. Yu's team established "Consun Chinese Medicines Research Centre for Renal Diseases" and "JaneClare Transdermal TCM Therapy Laboratory", respectively, in Hong Kong Baptist University.
Prof. Yu serves as Editorial Board Member/Associate Editor/Executive Editor/ Consulting Editor for more than 30 journals, e.g. LiShizhen Medicine and Materia Medica Research, BMC Complementary Medicine and Therapies, Current Topics in Nutraceutical Research, Journal of Alternative, Complementary & Integrative Medicine, Pharmacological Research.
Research Interests
1) Pharmacology of Chinese medicines, focusing on the mechanisms of action of anticancer, anti-inflammation and melanogenesis-modulation herbs; 2) Unique processing of Chinese medicinal herbs, focusing on the mechanisms underlying processing of Chinese medicines, standardization of adjuvant materials for the processing of Chinese medicinal herbs, and quality control of decoction pieces.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Scholars
Collaborations and top research areas from the last five years
-
-
Does dihydroartemisinin overcome vemurafenib resistance in melanoma by suppressing FLI1 expression?
1/01/23 → …
Project: Research project
-
Ginsenoside Rg3 and Artesunate Synergistically Overcome Sorafenib Resistance in Hepatocellular Carcinoma: Pharmacological Effects and Mechanisms of Action
1/12/22 → 30/11/25
Project: Research project
-
Does upregulating RNF125 expression with luteolin overcome vemurafenib resistance in melanoma?
1/01/22 → 31/12/24
Project: Research project
-
基於miR-142-3p/FAM98A通路研究槐花散抗結直腸癌的機制
YU, Z., CHEN, Y., WU, Y., AMIN, A., WU, J., WANG, X. & LI, S. M. A.
1/01/22 → 31/12/25
Project: Research project
-
An essential Noc3p dimerization cycle mediates ORC double-hexamer formation in replication licensing
Amin, A., Wu, R., Khan, M. A., Cheung, M. H., Liang, Y., Liu, C., Zhu, G., Yu, Z. L. & Liang, C., Mar 2023, In: Life Science Alliance. 6, 3, 22 p., e202201594.Research output: Contribution to journal › Journal article › peer-review
Open Access -
Anti-Rheumatoid Arthritis Mechanisms of a Herbal Formula Comprising Rosae Multiflorae Fructus and Lonicerae Japonicae Flos
Yu, Z., 28 May 2023.Research output: Contribution to conference › Conference abstract › peer-review
-
Arabidopsis DXO1 activates RNMT1 to methylate the mRNA guanosine cap
Xiao, C., Li, K., Hua, J., He, Z., Zhang, F., Li, Q., Zhang, H., Yang, L., Pan, S., Cai, Z., Yu, Z., Wong, K. B. & Xia, Y., 13 Jan 2023, In: Nature Communications. 14, 12 p., 202.Research output: Contribution to journal › Journal article › peer-review
Open Access2 Citations (Scopus) -
A traditional Chinese medicine prescription is beneficial in treating rheumatoid arthritis
Yu, Z., Feb 2023.Research output: Contribution to conference › Conference abstract › peer-review
-
A traditional herbal formula restrains bone erosion in experimental models of rheumatoid arthritis
Chen, Y., Wu, J. & Yu, Z., 22 Jun 2023, p. 29. 1 p.Research output: Contribution to conference › Conference abstract › peer-review
Prizes
-
File
-
Certificate for Excellence for an abstract presented at the 2022 World Federation of Chinese Medicine Societies Meeting
FAN, Xiaoyun (Recipient), WU, Ying (Recipient), FU, Xiuqiong (Recipient) & YU, Zhiling (Recipient), 23 Jun 2023
Prize: Award
File
Activities
-
A traditional Chinese medicine prescription is beneficial in treating rheumatoid arthritis
Zhiling YU (Plenary/keynote speaker)
28 Feb 2023 → 2 Mar 2023Activity: Conference/talk/lecture/symposium/speech/workshop, etc › Event organized by non-HKBU units
-
A herbal formula restrains bone erosion and inhibits osteoclastogenesis in collagen-induced arthritis rats
Yingjie CHEN (Participant) & Zhiling YU (Speaker)
30 Oct 2022Activity: Conference/talk/lecture/symposium/speech/workshop, etc › Event organized by non-HKBU units
-
Phytomedicine (Journal)
Zhiling YU (Associate editor)
1 Sept 2021 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Pharmacological Research (Journal)
Zhiling YU (Editor)
1 Aug 2019 → …Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
中華中醫藥學會中藥炮製分會 (External organisation)
Zhiling YU (Director/non-executive director)
1 Sept 2019 → …Activity: Membership › Membership of board/committee/council